Harvard Pilgrim Health Care Home
  HPHConnect
 
  Learn more.
  Sign up for HPHConnect.
Medical Management
E-Transactions
HPHConnect
Pharmacy
For Your Patient
News Center
Network Matters
Newsletter Archives
Newsletter Registration
Newsroom
Office Support
Products
Provider Manual
Medicare Advantage
Research & Teaching
Resources & Links
 
Print    Text Size

Network Matters
News and Information for the
Harvard Pilgrim Health Care Network

January 2014

Medical Policy for Genetic Testing 


Harvard Pilgrim has developed and established a medical policy for genetic testing, which includes newborn screening, diagnostic testing, carrier testing, prenatal testing, preimplantation testing, predictive and presymptomatic testing, and forensic testing. The new policy took effect on January 1, 2014.

Harvard Pilgrim will cover genetic tests when the following conditions are met:

  • A member displays clinical features or is at direct risk of inheriting a known mutation (pre-symptomatic); or after history, physical examination, pedigree analysis, genetic counseling, and completion of conventional diagnostic studies, a definitive diagnosis remains uncertain and a gene-linked disease is suspected; and
  • The result of a test will directly impact a member’s clinical treatment or management

Some tests, such as preimplantation genetic testing, may require prior authorization; please refer to the appropriate prior authorization medical review criteria for covered indications.

Harvard Pilgrim does not cover genetic testing in the following situations:

  • When the testing is used to inform the medical management of an individual’s family member
  • To confirm a diagnosis that can be established through other clinical evaluations
  • Forensic genetic testing

For the complete information, please see the Genetic Testing Medical Policy.

Email this article to a colleague   

Receive Network Matters by e-mail

Network Matters Archives

Download printer-friendly version

HPHCURRENT EVENTS

Commitment to the Principles of Centered Care

Reminder: Electronic Funds Transfer is Now Available

CLINICIAN CORNER

Update: Aloxi, Anzemet, and Emend Prior Authorization Medial Review Criteria

New Medical Policy: Cell-free Fetal DNA Testing

Medical Policy for Genetic Testing

Reminder: Measures Aimed at Boosting SNF/PCP Care Coordination

P&T Committee Updates

Specialty Pharmacy Updates

Club Drugs: Emerging Trends and Patterns

OFFICE ASSISTANT

2014 Fee Schedule Updates

Update: Gastroenterology Payment Policy

New CMS 1500 Claim Form Now Accepted

PUBLICATION INFORMATION

Eric H. Schultz,
President and Chief Executive Officer

Richard Weisblatt PhD,
Senior Vice President, Provider Network

Annmarie Dadoly,
Editor

Kristin Edmonston,
Production Coordinator